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Abstract
Background: In response to growing demand for urgent care services there is a need to implement more effective
strategies in primary care to support patients with complex care needs. Improving primary care management of
kidney health through the implementation of ‘sick day rules’ (i.e. temporary cessation of medicines) to prevent
Acute Kidney Injury (AKI) has the potential to address a major patient safety issue and reduce unplanned hospital
admissions. The aim of this study is to examine processes that may enable or constrain the implementation of ‘sick
day rules’ for AKI prevention into routine care delivery in primary care.
Methods: Forty semi-structured interviews were conducted with patients with stage 3 chronic kidney disease and
purposefully sampled, general practitioners, practice nurses and community pharmacists who either had, or had not,
implemented a ‘sick day rule’. Normalisation Process Theory was used as a framework for data collection and analysis.
Results: Participants tended to express initial enthusiasm for sick day rules to prevent AKI, which fitted with the
delivery of comprehensive care. However, interest tended to diminish with consideration of factors influencing their
implementation. These included engagement within and across services; consistency of clinical message; and resources
available for implementation. Participants identified that supporting patients with multiple conditions, particularly with
chronic heart failure, made tailoring initiatives complex.
Conclusions: Implementation of AKI initiatives into routine practice requires appropriate resourcing as well as training
support for both patients and clinicians tailored at a local level to support system redesign.
Keywords: Acute Kidney Injury, UK, Primary care, Normalisation process theory, Kidney disease, Qualitative,
Multimorbidity
Background
Acute Kidney Injury (AKI) is a major patient safety issue
[1]. It is a clinical syndrome characterised by rapid
reduction in kidney function [2]. Globally, AKI affects
approximately 13.3 million people per year despite the
fact that it is mostly preventable with timely intervention
[3]. In the UK, it is estimated to affect between 12 and
14 % of all hospital admissions [4], with almost two
thirds of patients having developed it in community
settings [5]. AKI is associated with longer lengths of stay
and increased requirement for renal replacement therapy
[6]. Recently, it has been estimated that AKI is associated
with over 40,000 inpatient deaths in England and the an-
nual cost is estimated at £1.02 billion, or 1 % of the NHS
annual budget [4]. From 2010 to 2011, the cost of caring
for patients with AKI post hospital discharge was £190
million, thus there is a need to prevent, or reduce, the oc-
currence of AKI [4, 7]. Optimal care including a focus on
targeting interventions in primary care has the potential
to save up to 12,000 lives per year and produce substantial
savings for patients and the NHS [4, 8].
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Within NHS England’s patient safety domain, the
national Think Kidney programme has been established
to tackle harm associated with AKI [9]. In parallel, the
growth in demand for urgent care services increases
annually and this trend is expected to continue as people
live for longer and have more complex care needs [10].
Key measures to address current demands include a more
responsive urgent care service outside of hospital with a
need for the provision of better support for people to self-
care [10]. An underpinning component of high quality care
is self-management support [11]. The recent Keogh review
highlights the need to implement better self-management
options including care planning to help patients ‘deal with
their own condition before it deteriorates or additional help
is required’ [10].
The prevention of AKI is one pathway to reducing
demands on urgent care. Certain patient populations
are particularly at risk of complications associated with
AKI during episodes of acute illness (e.g. sepsis caused
by gastroenteritis). These include patients with dia-
betes, heart disease, cancer, pre-existing reduced kidney
function (chronic kidney disease (CKD)) as well as pa-
tients with cognitive decline who are reliant on carer
support [2, 3, 12]. In order to prevent AKI, the National
Institute of Health and Care Excellence (NICE) recom-
mended the need to communicate risk of AKI with
patients, including the need to maintain fluid balance
and consider temporary cessation of certain medicines
(including angiotensin-converting-enzyme (ACE) Inhib-
itors) during episodes of acute illness [4, 12, 13]. Re-
sources to support medicines self-management during
acute illness have been termed ‘sick day rules’ or sick
day rule guidance [14, 15]. The planning for changes to
medication regimes during acute illness already occurs
for other conditions, in particular sick day rules for
type 1 diabetes [14], where patients temporarily adjust
their medicine regime during an acute illness for a
short period and then restart them. However, although
recommended, currently there remains limited evidence
surrounding their implementation and effectiveness. In
the context of AKI being viewed as a key clinical prior-
ity for improving patient safety and outcomes [6, 9, 16],
our study aimed to identify factors that enable or con-
strain the implementation of sick day rules in primary




A qualitative study design was adopted and Normal-
isation Process Theory (NPT) was used as a sensitising
concept for data collection and analysis [17, 18]. NPT
is a theory of healthcare implementation and offers a
structure for understanding practises that enable or
constrain the integration of an intervention (such as
‘sick day rules’) into routine care [17, 18]. NPT focuses
on the work that different actors (e.g. GPs, nurses or
pharmacists) have to accomplish to implement the
new intervention into practice [18].
Sampling
We purposively sampled participants (General Practitioners
(GPs), practice nurses and community pharmacists) from
primary care sites who had experience of implementing a
sick day rule plan to prevent AKI in two geographical
locations as well as participants from a site who had no
experience of using sick day rules. Participants were
also purposefully sampled in terms of a range of profes-
sions. Clinicians were recruited through snowball sam-
pling using existing contacts, the National Institute for
Health Research Clinical Research Network and the
Royal Pharmaceutical Society and were sent the study
information sheet. For practices that had not imple-
mented a sick day rule plan, a prototype plan developed
in conjunction with patient and public involvement
partners was discussed (see Additional file 1). Practices
that had implemented a sick day rule plan had access to
a range of tools: i. a patient leaflet; ii. enhanced laboratory
co-ordination; iii. credit card sized patient reminder cards;
iv. improved access to a local nephrology team; v. website
for professional reference; vi. health professional education.
The plan developed as part of this project (see Additional
file 1) built on the discussions during the interviews but
was not the same as the plan used in these existing sites
(for more information on the development of this
initiative see http://heeminnovation.co.uk/projects/
improving-the-outcome-of-aki-in-primary-care/).
In recognition of guidance that patients with CKD
are at increased risk [2, 12], we used a convenience
sample of patients who had a known diagnosis of stage
3 CKD and were prescribed either an ACE inhibitor or
Angiotensin Receptor Blocker (ARB). Patients were
screened to ensure they met the study inclusion cri-
teria and those who were eligible were sent the patient
information sheet from their General Practice.
Data collection
Forty semi-structured interviews were conducted with
all participants by RM. Interviews were conducted
between May to September, 2014. Interviews were
conducted either at participants’ surgeries, community
pharmacies or homes. Interviews ranged from 14 to
107 min (average 40 min). The interviews were digit-
ally recorded and professionally transcribed. Inter-
views explored the management of acute episodes of
illness as well as the work required to implement ‘sick
day rules’ into everyday practice. This included explor-
ing, the work of embedding and integrating ‘sick day
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rules’ into: 1) clinical encounters; 2) practice organisa-
tion; 3) links with other services including with com-
munity pharmacies; and 4) individuals’ everyday lives
(see Tables 1 and 2). This qualitative study adhered to
the qualitative research guidelines (RATS) [19].
Data analysis
Two researchers read the transcripts independently (RM
and TB) and through comparative analysis independently
noted down main themes and sub-themes that emerged.
Key themes were identified through discussion between
RM and TB. Key themes and quotes were circulated to all
the authors for comments and discussion. A final set of
themes and sub-themes were agreed by all authors. Atlas ti
7.5 qualitative analysis software was used to support
analysis. NPT was used within the analysis as a sensitising
concept to the work involved in implementation across
primary care [17, 18]. NPT has four main underlying
constructs that influence implementation: coherence (i.e.
meaning and sense making by the participants); cognitive
participation (i.e. engagement and commitment by the par-
ticipants); collective action (i.e. the work needed to make
the intervention function); and reflexive monitoring (i.e. re-
flection and appraisal of the intervention by participants)
[20]. We used NPT to create a framework to examine the
context of implementation and combined this with a the-
matic approach to examine and refine emerging themes
[21]. Analysis examined all the data across and within each
setting using our research aims.
This study was given ethical approval by Research
Ethics Committee North West-Preston reference 14/
NW/0099.
Results
Twelve GPs, 8 Practice Nurses, 12 Pharmacists and 10
patients were interviewed (see Table 3). In general,
participants tended to express initial enthusiasm and
understanding surrounding the rationale for sick day
rules to prevent AKI. Sick day rules were seen to fit with
the delivery of comprehensive care.
I’d use it with my patients who are identified as CKD,
who are on an ACE or an ARB…I don’t think there’s
any reason not to give all of them this, the same way
as you would a diabetic patient, you know, the sick
day rules for their insulin
ID04 (Practice Nurse)
Table 1 Interview schedule for clinicians
NPT construct Questions
Coherence • What are your initial thoughts?
Coherence • How would you use it?
Cognitive Participation • How does it fit with your current practice? What considerations of renal function do you give during episodes
of acute illness for people with CKD?
Cognitive Participation • Do you consider temporarily stopping certain medications during times of acute illness with patients with CKD?
Cognitive Participation • What might influence it becoming a routine part of practice?
Collective Action • Do you discuss with patient with CKD during their review appointments how they should manage an episode
of acute illness?
Collective Action • How does this change when people have multiple conditions?
Coherence • How do you manage patients with coronary heart failure to prevent AKI? What would influence your decision
for recommending patients to stop ACE inhibitors or ARBs or NSAIDS?
Coherence • Can you give me some examples of when you have temporarily stopped medications for patients with other
conditions? What are the implications in the practice? How did you remind patients when they had to start
taking the tablets again?
Cognitive Participation • How will you identify the most vulnerable 2 %? What is the focus of their care for you (eg unplanned admissions)
and what will that entail?
Collective Action • How would the action plan fit with your plans for supporting the most vulnerable 2 %?
Collective Action • How do you co-ordinate with hospital staff about medications people are taking and their conditions?
Collective Action • What happens when someone is discharged from hospital? What information are you given and who is this from?
Collective Action • How is this co-ordinated between the hospital and your practice/pharmacy? How do you co-ordinate this with the
local pharmacists/GPs?
Reflexive Monitoring • What are some of the logistical issues in managing changes to medications?
Collective Action • How do you co-ordinate changes in medicines? What are the implications in the work that you have to do to
manage it and to restart medicines?
Collective Action • What other services do you co-ordinate with to manage patients with acute illnesses? (eg community matrons
and district nursing team)
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Patient participants also described an initial engage-
ment with the idea of temporary cessation of medi-
cines if directed by a healthcare professional to stop
the medicines and an explanation of why there would
be a change in their previous response to these acute
illnesses. Patient participants also raised uncertainty
about whether they would be able to distinguish be-
tween the symptoms of different conditions which
may affect their recognition of when to begin tempor-
ary cessation.
It’s never happened in the past. I’ve never been advised
to stop taking them but if the doctor advised that, I’d
stop taking them…Listen, if the doctor tells me that I
need to take a tablet I take it. If he says, stop, I stop. I
have faith in the man… I have flu vaccinations so I
don’t often get flu that I’m aware of and I don’t
actually go to the doctor with it…if I’ve had the flu, if
it was flu, I’ve just carried on… I’m not sure whether,
you know, you just think it’s a bad cold. It could be flu,
but it might just be a bad cold, so I don’t know, but if
I was to go to the doctor and he said, you’ve got flu,
stop taking x, y and z, I’d stop taking them.
ID12 (Patient)
However, during the course of interviews, initial
interest tended to be diminished by a range of factors
influencing implementation. Factors affecting the up-
take and use of sick day rules related to collective
engagement within and across services, uncertainties
around embedding sick day rules into existing clinical
care, as well as resourcing the integration of AKI initia-
tives into routine practice.
Collective engagement with sick day rules
It was considered an essential requirement by patients
and healthcare professionals that a consistent message
about temporary medicine cessation and AKI preven-
tion was given by all health care professionals.
Everybody pulling together and giving out the same
message, including the receptionists. Everybody…It
will be good practice every time you see them to say,
and you do have your action plan, or you do have
your sick day rules.
ID04 (Advanced Nurse Practitioner)
From a community pharmacy perspective it was seen
as important that the implementation of sick day rules
did not disrupt working relationships with local GPs.
The GPs are trying to make sure people do come to
us…I’d rather we be able to do something with the
blessing of the local surgeries than sending them back,
I think they wouldn’t want that.
ID14 (Pharmacist)
In order to engage, pharmacists needed to know that
GPs were on board with this initiative, with a preference
expressed for adopting a secondary reminder role that
was more congruent with their existing remit.
Table 2 Interview schedule for patients
NPT construct Questions
Coherence • What do you think of the action plan?
Coherence • If you imagine you had to use it: can we talk through the process that you would go through?
Cognitive Participation • Would you stop temporarily tablets if they were to manage pain? A heart condition? What would
influence you in making that decision?
Collective Action • Who do you think should give you this?
Collective Action • Who do you think would support you to stop tablets for a short period?
Collective Action • Would you want to be reminded at the end of the tablet break that you should start taking them again?
Coherence • Would you use it?
Collective Action • What happens during review appointments with GPs and practice nurses?
Coherence • Have you discussed what you should do if you start to feel unwell eg flu?
Coherence • What do you do when you’re starting to feel unwell?
Coherence • When do you go to see your doctor/nurse?
Cognitive Participation • Do you currently take any medications?
Cognitive Participation • Do you have a system for managing them?
Coherence • Have you ever had to stop taking any of your tablets for a short time because you were ill?
Coherence • Were you given any information (written or verbal)?
Collective action • What happens when you visit community pharmacists?
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I think it’s a really good idea yeah, and as pharmacists
we’d be happy to remind patients like we do with don’t
take your statin things
ID15 (Pharmacist)
Boundaries of responsibility (both legal and profes-
sional) were highlighted in terms of having a role in
discussing the temporary cessation of medicines. These
boundaries were reinforced by limits to professional
education and training. As with community pharmacists,
practice nurses also needed to ensure GP engagement in
order to have confidence to implement sick day rules
into their clinical practice.
I would consult with the doctor and let him make
the decision. I would never do it independently…
Because I wouldn’t feel competent, or confident…no
court in the land would support me. It would be very
wrong and very unprofessional.
ID01 (Practice Nurse)
Patients also expressed increased confidence in medi-
cines management when there was evidence of common
agreement with professionals involved in their care. Pa-
tient accounts depicted the need for their care providers
to have access to their comprehensive information to
make informed clinical recommendations. Whilst this
was not always considered to have to be the GP, the GP
role as the link between primary care providers and con-
sultants gave patients’ confidence that they would have
access to all necessary information to ensure their safety.
One of the things that my GP thinks about doing…he
will make sure that he gets confirmation from the
renal consultant that it’s okay to do it. They’re very
wary of prescribing for me… There’s a communication
between the two.
ID35 (Patient)
In practices that had experience of using sick day rules, co-
ordination across services was considered important when
considering the implementation of AKI initiatives. Simply
giving the sick day rule plan on its own tended to be seen as
insufficient by clinicians who had implemented a plan.
We didn’t because we did it all in-house, but that
would’ve been another way we could’ve done it through
the local pharmacy….we had a list and we had all
these leaflets and we wanted to get them out as quickly
as possible. But yes, I mean in retrospect involving the
local pharmacist would’ve been a good idea.
ID26 (GP)
In order to have confidence to implement sick day
rules to prevent AKI, participants’ accounts highlighted
the need for wider, collective, commitment with the ini-
tiative and that clarity in roles and responsibilities was
central to this process.
Yes, I think the community matrons are a resource
that could really do this. Them, the heart failure
nurses as well, so I think there’s a lot within the
community who could…I mean, we’re meant to tie all
this stuff together…And then, there’s the nursing home
staff…the problem is it will escalate because no one
wants to take responsibility, and the buck’s got to stop
somewhere.
ID03 (GP)
Patient participants also identified the need for sup-
ported approach to temporary cessation where they were
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able to contact their GP if they had any questions and the
action plan acted as an aide memoire that would have to
be stored in accessible place, such as with their medicines.
The problem is, as you get older your memory isn’t
great, it’s hard to remember to do things, especially if
you’re not well…I would keep it with my medications so
that I’m, you know, I have a special drawer that I keep
all my pills, which unfortunately are quite a lot. And I
would keep it there; you know, fully filled in and
perhaps have my doctor’s contact number on it as well.
ID20 (patient)
Embedding sick day rules into clinical encounters
Whilst recognising that sick day rules were not currently
part of routine practice, health professionals suggested
that they may be relevant for a range of patients. Partici-
pants suggested that sick day rules could be implemented
in review appointments. Episodes of acute illness were
also considered an ideal opportunity to remind patients of
sick day rules, with IT systems prompting reminders.
We are entirely reliant on the computer, so as soon as
you entered any patient’s notes, if they were one of
those, it came up with a prompt that you had to press
a button to get rid of, so you couldn’t really avoid it.
ID28 (GP)
Community pharmacists identified opportunities they
had for reminding patients about AKI prevention as they
dispensed medicines. They also highlighted their limited
access to diagnostic information (such as knowledge of a
patient’s kidney function), which was seen to constrain
their potential to optimise conversations with patients.
I think as pharmacists we could deliver it in a positive
way because we’d have the time to sit with the patient, do
a medicines review, or even without a medicines review
the fact is that when we’re dispensing any medication
you’ve got time to really engage with them, probably more
so than the GP would… But identifying the patients in
the first place would be a big stumbling block for us.
ID18 (Pharmacist)
Some patient participants similarly described a more lim-
ited confidence in the advice given by the pharmacists as
they did not necessarily have access to patient information.
I:..who it should come from, is it the GP or would it be
the nurse or the pharmacist?
R: GP or nurse…I suppose a GP or the nurse at the GP
centre would know more about my history than the
pharmacist would, so I would be more likely to take
their word for it.
ID38 (Patient)
Practice nurse accounts varied in terms of the ease
with which they may implement sick day rules within
their clinical work. For some, implementation was
considered relatively straight forward as patients
already attended review consultations with an existing
expectation that education and support would be
provided.
For all the patients who would be coming in to me
for the reviews, for myself to do it I wouldn’t see it
as a problem… because we’re talking about a lot of
things with them, I do feel it’s not as though it’s
going to take me another 20 min to go through …
it’s quite self-explanatory. You’d be documenting
the medicines… I could use it.
ID09 (Practice Nurse)
However, for other practice nurses, there was uncer-
tainty on how to embed sick day rules without creating
additional workload. Though participants considered
kidney function as part of a comprehensive approach to
care, it was not necessarily clear how to integrate AKI
initiatives into existing practices given other clinical pri-
orities and patient safety issues.
You look at them holistically… It’s not just the flu.
You’ve got to look at everything else that’s going on…
you get patients obviously with multiple medical
problems and you have to try and remember to
include everything in your consultation. It’s
sometimes quite hard.
ID01 (Practice Nurse)
Similarly, some GPs reflected a sense of workload
pressure and the challenge in determining which infor-
mation and guidance to give precedence.
I know as a GP I don’t know everything but I
know that when problems arise I need to start
tackling them, and how do I tackle them really? …
I mean general practice is to do with assessing
risk…when new information comes in it’s assessing
the need and the risk of that and how quickly I
need to do it
ID13 (GP)
Whilst deemed important, few GPs who had not used
a sick day rule plan described currently discussing kid-
ney care with patients in the context of preventing AKI
during episodes of acute illness.
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We’re pretty good now at telling people how to take
their ACEs. We’re not so good at telling people to
stop…when people are unwell, I think that that slips
our mind… the majority of these illnesses may well
start off the majority of times be self-limiting, they
don’t get to us… But then, that’s predisposing them to
develop other things and progress to having acute
kidney injury, whereas if they do know to stop them
each time then that’s much better.
ID03 (GP)
Again, across clinician interviews, professional respon-
sibility for managing risk was seen as a key driver of
clinical care. In this context, they described trade-offs
and uncertainties when considering kidney function in
the context of clinical management of patients with
complex co-morbidities including heart failure.
You look at what effect, you know, any diuretics they’re
having… What’s their blood pressure doing, because if
their blood pressure has plummeted as well then, yes,
it can make sense to stop things, so it’s weighing up all
of these different things.
ID03 (GP)
Resourcing implementation of sick day rules
Capacity within primary care to maintain the potential
level of work required was raised by the majority of clin-
ician participants. Linking the implementation of sick day
rules to existing incentives structures (such as the chronic
illness review or the Medicine Use Reviews (MUR) [22])
were mechanisms identified to support this additional
work. However, whilst it was seen as a small amount of
work with each individual, the cumulative effect was
deemed inhibitive.
If they were on medication, we’d just stick a pharmacy
sticker on the back, highlight it, and then we’d go out
and have a five minute chat to patients… although
we’d have a lot…the only thing that I worry about
then is having to do a lot of five minute chats and the
workload.
ID15 (Pharmacist)
A major limitation to the implementation of sick day
rules to prevent AKI was how to support patients who
used dosette boxes. The additional work involved in
identifying, removing and resealing the tablets was con-
sidered to be too much unless remunerated.
What we would do is help them identify which ones they
need to not take…we don’t interfere with blister packs
once they go out. So we wouldn’t be prepared to take
them out and reseal them because then that’s more
unremunerated work, …If they’re reissued it’s fine, we
just redo them…from new stock, and that’s fine, but
that’s part of the politics of this whole area really.
ID30 (Pharmacist)
Participants highlighted the roles of other support staff
that may need to be resourced in order to successfully
implement the process of temporary cessation. This
included costing the potential increase in workload for
pharmacy delivery drivers associated with changing
prescriptions and managing the dosette boxes.
What the GP might phone and say I want to take this
patient, well we get phone calls like that anyway that
doctors quite often do the home visits and changing
medications… if this is something that’s…rolled out, we
will be doing a lot of patients that have, especially
around winter time as well when a lot of these elderly
patients are getting flu…we may need to employ
another driver to, you know…
ID15 (Pharmacist)
In general practice this additional workload could also
have implications for receptionists and clinicians.
It would need a telephone consultation to make sure
that the patient has restarted their medication,
because like I said, people will stop, it’s remembering
to get started on it again. …I think we probably would
get a lot of phone-calls, and they would obviously go
through to reception and not to us. So that might be a
bit of an issue.
ID23 (Practice Nurse)
Explaining the purpose of sick day rules was of par-
ticular importance because of the potential change to
patients’ normal acute illness response and expectations
of care provision.
It would just be absolutely part of what we said before.
When you put them on it, you say, you know, I know
the media says don’t come in with a cold or flu, but in
your case it’s a little bit different. You’re older, your
kidneys aren’t working as well as they used to.
ID04 (Advanced Nurse Practitioner)
Finally, a sense of fatigue surrounding the changing na-
ture of financial incentivisation of primary care was identi-
fied as a factor that might influence their implementation.
I think there’s huge pressure at the moment…Every
year, there’s a whole new set of rules. Whether it be
QOF or LESs and DESs, which require very little that
directly benefits patients…I think there was a great
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fatigue about that. And there was virtually nothing
had come up that would ever improve the quality of
patient care obviously, like this would
ID11 (GP)
Discussion
The study analysis highlighted tensions between the pre-
vention of AKI as a fundamental component of safe care
and the reality of embedding it within routine practice.
The study analysis suggested a common understanding
(coherence [18]) concerning the rationale for sick day
rules to prevent AKI. However, in order to have confi-
dence to engage with their implementation, participants’
accounts highlighted a need for clarity of roles and respon-
sibilities within and across services. Professionals’ capacity
to undertake the work surrounding temporary cessation
was deemed limited unless adequately resourced.
Central to current clinical recommendations is the iden-
tification of risk factors (e.g. taking certain medications
during acute illness) and their temporary removal [12] but
participant accounts stressed the complexities of this in
practice. In particular, relationships between professionals
across primary care had the potential to support or under-
mine implementation. The micro level systems of General
Practices, or Pharmacies, influenced implementation and
was shaped by concerns about capacity to undertake
additional work, variable access to patients’ diagnostic
information and the cumulative effect of processes to
work (such as reissuing dosette boxes) that would need
to be undertaken. At a macro level, the organisational
context that was needed to support implementation
was a need to have clear guidance outlining boundaries
of responsibility for giving recommendations.
Systematic reviews of self-management for patients with
chronic obstructive pulmonary disease indicate action plans
to support the management of exacerbations are only likely
to have a positive effect on quality of life and health care
utilization if delivered as part of a multifaceted programme
[23–25]. Key themes that emerged from this study also sug-
gest that sick day rules alone are unlikely to have effect on
the prevention of AKI without resourcing wider strategies
to support implementation (including support to address
the issue of responsibility across professions).
AKI prevention was considered to respond to a clinical
need rather a policy driven approach. Patients’ prioritisation
of conditions may also influence the adoption of prevention
strategies. Prioritisation of conditions changes over time
[26] and may be influenced by the timing of information
provision and education around diagnosis. In this context,
care plans (such as sick day rules) may be a tool to support
the discussion of AKI prevention and renal function.
In terms of implementing sick day guidance, health pro-
fessional concerns may reflect current limited evidence sur-
rounding the temporary cessation of medicines during
episodes of acute illness [27]. Though recommended in
clinical guidance [8, 12] hypotheses also exist that continu-
ation of ACE Inhibitors may result in a reduction in glom-
erular filtration (reflected in Serum Creatinine rise) but
have a protective effect on renal tubular function [28, 29].
As such a large scale evaluation measuring all-cause mor-
tality or any benefits and harms of sick day rule use in dif-
ferent patient populations is needed to determine clinical
and cost-effectiveness.
Participants’ accounts illuminate the distributed nature of
work surrounding the implementation of NICE guidance
regarding temporary cessation of medicines for AKI pre-
vention. Integrating initiatives to prevent AKI within exist-
ing funding structures may help resource additional work
identified. For example, the New Medicine Service (NMS)
[25] as well as the MUR [22] may support dialogue within
community pharmacy. Aligning key policy initiatives is a
necessary step. In April 2014, NHS England launched the
National AKI Programme [9]. At the same time, the
Unplanned Admissions Enhanced Services was introduced
in which GPs are funded to identify and proactively
case manage patients deemed most at risk of emer-
gency hospitalization [30]. Research evaluating the in-
corporation of targeted actions plans to prevent AKI
compared with the use of more generic care plans to
avoid unplanned hospitalization may also be warranted
[29, 31]. NPT helped to illuminate the context and local-
ised systems approach that may need to be adopted to
work with local stakeholders to implement sick day guid-
ance. In essence, this implementation should include a
collective space for different health professionals to meet
and discuss ongoing implementation, and to address
issues of communication and clarity of roles and responsi-
bilities to ensure engagement and participation by all
stakeholders.
Strengths and limitations
This study draws on both prospective accounts of GP, Prac-
tice Nurse, Community Pharmacist and patient accounts
about the potential enablers and constrainers of implemen-
tation as well as retrospective accounts of those who have
already implemented a sick day rule plan. This is a strength
of this study as it supports an understanding of the pro-
cesses of implementation across different settings. As AKI
prevention is a national patient safety priority, there is a
need to understand these processes and to recognise the
realities of everyday practice and management to optimise
the implementation of AKI prevention strategies that
supports both patients and clinicians. Use of NPT as a sen-
sitizing tool [18] helped illuminate different types of work
(e.g. co-ordination between professionals (i.e. collective
action) or engagement with specific tasks or responsibilities
(i.e. cognitive participation)) surrounding the implementa-
tion of sick day rules. One limitation is that in practices that
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had already implemented a sick day rule plan, there were
no data about changes to rates in community-acquired AKI
following implementation. Whilst this will be important for
future studies, this study was focused on examining the
processes of implementation this enabled us to understand
how sick day rules were embedded, or not, within different
local primary care systems. Understanding these processes
of implementation is important for developing future
national interventions. Further research in different set-
tings (such as nursing homes) is needed and explor-
ation of a wider range of patient and carer experience
concerning the use of sick day rules in everyday life,
such as during an acute illness episode.
Conclusions
This study sought to understand the implementation of
sick day rules to prevent AKI in primary care. Although
seen to fit with the delivery of comprehensive care, the
findings highlight the need for shared understanding of
roles and responsibilities in order to become part of rou-
tine practice. Consideration should be given to resour-
cing AKI initiatives through integration into existing
funding mechanisms as well as developing an evidence
base concerning their effectiveness.
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